PerkinElmer Genomics makes two announcements
FDA addresses variant databases and germline tests
Agilent targets clinical market
In what is viewed as a step forward for NGS-based clinical testing, the US Centers for Medicare & Medicaid Services (CMS) announced this month a final National Coverage Determination (NCD) for FDA-approved NGS tests for advanced cancer (defined as either recurrent, relapsed, refractory, metastatic, or advanced stages III or IV) patients as long as certain […]
New investments in manufacturing and R&D promised
Illumina announces Chinese partnership
Verogen launches Illumina technology–based forensics products
Oxford Nanopore wins latest round
BGI announces new initiatives
Next-generation Ion GeneStudio S5 Series offers more flexibility and more cost savings – Contributing author: Al Saint Jacques
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.